Stock GH GUARDANT HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Guardant Health, Inc.

Equities

GH

US40131M1099

Market Closed - Nasdaq
Other stock markets
 21:00:00 08/05/2024 BST 		5-day change 1st Jan Change
18.64 USD -0.96% Intraday chart for Guardant Health, Inc. +2.08% -31.09%
04-29 Canaccord Genuity Adjusts Price Target on Guardant Health to $30 From $45, Maintains Buy Rating MT
04-22 Sector Update: Health Care Stocks Increase Late Afternoon MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting
CI
Guardant Health, Inc. Announces Results from the ECLIPSE Study Showing the Effectiveness of Its Shield Blood Test for Detecting Colorectal Cancer
CI
Guardant Health Q4 Adjusted Loss Narrows as Revenue Rises
MT
Earnings Flash (GH) GUARDANT HEALTH Posts Q4 Revenue $155.1M, vs. Street Est of $150.8M
MT
Guardant Health, Inc. Provides Earnings Guidance for the Year 2024
CI
Guardant Health, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Guardant Health Reports Preliminary Q4 Revenue
MT
EDX Medical maintains confident outlook; implements biopsy tests
AN
Guardant Health Reports Tentative Date for US FDA Advisory Panel Review of Shield Blood Test
MT
Guardant Health, Inc. Announces Tentative Date of FDA Advisory Panel Review of Shield(TM) Blood Test
CI
Cancer Research UK and Guardant Health Launch Collaboration to Advance Cancer Research and Clinical Development Activities
CI
Guardant Health's Q3 Non-GAAP Loss Narrows, Revenue Rises
MT
Guardant Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Earnings Flash (GH) GUARDANT HEALTH Posts Q3 Revenue $143M, vs. Street Est of $137.4M
MT
Guardant Health, Inc. Provides Revenue Guidance for Full Year 2023
CI
Zydus Lifesciences, Guardant Health to Co-Market Cancer Biopsy Tests in India, Nepal
MT
Guardant Health, Inc. and Flatiron Health Announce Integration of Guardant Genomic Profiling Tests into OncoEMR Platform
CI
Guardant Health, Inc. Announces Initial Results from the PEGASUS Trial
CI
EDX Medical inks distribution deal for Guardant's blood biopsy tests
AN
EDX Medical to Distribute Guardant Health's Cancer Genomic Tests in UK, Nordics
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GH Stock
  4. News Guardant Health, Inc.
  5. Highlights